Mesoblast (MESO) Net Cash Flow (2016 - 2023)

Mesoblast (MESO) has reported Net Cash Flow for 8 consecutive years, with $22.5 million the latest figure, recorded in Q2 2023.

• Quarterly Net Cash Flow rose 239.23% year-over-year to $22.5 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was $22.5 million (up 252.31% YoY) and the FY2025 annual result came in at $97.5 million, up 1273.74% from the prior year.
• Net Cash Flow improved to $22.5 million in Q2 2023 per MESO's latest filing, from -$18.8 million in the prior quarter.
• Over the last five years, Net Cash Flow for MESO reached as high as $81.0 million in Q1 2021 and fell as low as -$31.7 million in Q4 2020.
• A 5-year average of -$439500.0 and a median of -$18.3 million in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2020 — Net Cash Flow plunged 208.58% — and 2021, when it surged 491.98%.
• Year by year, Net Cash Flow stood at $46.4 million in 2019, then slumped by 168.33% to -$31.7 million in 2020, then jumped by 33.25% to -$21.2 million in 2021, then climbed by 12.66% to -$18.5 million in 2022, then soared by 221.59% to $22.5 million in 2023.
• According to Business Quant data, Net Cash Flow over the past three periods registered $22.5 million, -$18.8 million, and -$18.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.